Product Information
ZOMIG 2.5 MG NASAL SPRAY is a brand product labeled by Amneal Pharmaceuticals LLC, priced at $108.5647 per EA under NDC 64896008312. Its NADAC has been published 33 times since Feb 18, 2026.
FDA first approved this application on Sep 30, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Zolmitriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
64896008312
Classification
Brand
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
2/18/2026
Active Ingredients
ZOLMITRIPTANApproval Type
New Drug (NDA)
FDA Application
NDA021450FDA Approved
9/30/2003
TE Code
AB
On Market Since
7/15/2024
Pharmacological Classes
Price Statistics
The NADAC for ZOMIG 2.5 MG NASAL SPRAY has been published 33 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $108.5647 per EA |
|---|---|
| All-time high | $108.5647 (Sep 30, 2026) |
| All-time low | $108.5647 (Feb 18, 2026) |
| 52-week high | $108.5647 |
| 52-week low | $108.5647 |
| Median price | $108.5647 |
| Average price | $108.5647 |
| Largest weekly change | 0.0% (Feb 25, 2026) |
| Weeks tracked | 33 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Zolmitriptan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolmitriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOMIG 2.5 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for ZOMIG 2.5 MG NASAL SPRAY, manufactured by Amneal Pharmaceuticals LLC, is $108.5647 per EA (NDC 64896008312), effective Sep 30, 2026.
How has the price of ZOMIG 2.5 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for ZOMIG 2.5 MG NASAL SPRAY has held within roughly two percent of its current level. It has been tracked across 33 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for ZOMIG 2.5 MG NASAL SPRAY?
Since Feb 18, 2026, the NADAC for ZOMIG 2.5 MG NASAL SPRAY has ranged from a low of $108.5647 (Feb 18, 2026) to a high of $108.5647 (Sep 30, 2026), with a median of $108.5647 per EA.
Are there cheaper alternatives to ZOMIG 2.5 MG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of ZOMIG 2.5 MG NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZOMIG 2.5 MG NASAL SPRAY?
ZOMIG 2.5 MG NASAL SPRAY (NDC 64896008312) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a brand product.